Dec 20 (Reuters) - UK's competition regulator will refer Australian hearing device maker Cochlear's (COH) acquisition of Copenhagen-based Demant's DEMANT.CO hearing implants business Oticon Medical for an in-depth investigation.
UK's Competition and Markets Authority (CMA) said on Tuesday it will refer the 850 million Danish crowns ($121.14 million) deal to a phase 2 investigation as it could threaten competition. ($1 = 7.0167 Danish crowns)
News: COH UK regulator to launch deeper probe into Cochlear's takeover of Oticon Medical
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$303.78 |
Change
2.120(0.70%) |
Mkt cap ! $19.86B | |||
| Open | High | Low | Value | Volume |
| $303.79 | $304.22 | $300.12 | $51.31M | 169.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 77 | $302.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $304.30 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 21/08/2025 (20 minute delay) ? |
| COH (ASX) Chart |